Pezzolo, E. et al. 2026. Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis). Acta Dermato-Venereologica. 106, (Apr. 2026), adv–2025. DOI:https://doi.org/10.2340/actadv.v106.adv-2025-0193.